丸山徹 (Toru Maruyama) - マイポータル

基本情報

所属: 熊本大学薬学部熊本大学薬学部薬剤学教授

J-GLOBAL ID: 200901070988046333
researchmap会員ID: 6000005232

研究分野

ライフサイエンス / 医療薬学 /

経歴

2006年

熊本大学薬学部薬剤学教授
2006年

Professor, ,School of Pharmacy,Kumamoto University

学歴

論文

396

マクロピノサイトーシス誘導剤による舌下アレルゲン免疫療法の有効性向上

丸山徹, 一水翔太, 前田仁志, 小田切優樹, 渡邊博志

人工血液 32(1) 38-38 2024年11月
Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation

Hiroki Yanagisawa, Hitoshi Maeda, Isamu Noguchi, Motohiko Tanaka, Naoki Wada, Taisei Nagasaki, Kazuki Kobayashi, Gai Kanazawa, Kazuaki Taguchi, Victor Tuan Giam Chuang …

Redox Biology 76 103314-103314 2024年10月
Omega 3 Fatty Acids Attenuate the Acute Kidney Injury to CKD Transition and Renal Fibrosis: Identification of Antifibrotic Metabolites.

Kai Tokumaru, Tadashi Imafuku, Takao Satoh, Tomoaki Inazumi, Shu Hirashima, Ayano Nishinoiri, Taisei Nagasaki, Hitoshi Maeda, Yukihiko Sugimoto, Motoko Tanaka …

Kidney360 2024年9月11日
Qualitative and quantitative status of cytochrome P450s after the administration of a liposomal platelet substitute in rat liver.

Kazuaki Taguchi, Mai Hashimoto, Masahiro Tokuno, Shinji Takeoka, Toru Maruyama, Keishi Yamasaki, Masaki Otagiri

Xenobiotica; the fate of foreign compounds in biological systems 1-7 2024年8月1日
Contribution of Phe112, Ser114, and Tyr115 to Drug-Binding Selectivity in the A Variant of α₁-Acid Glycoprotein

Yuka Nakamura, Hiroshi Watanabe, Teruya Nakamura, Mami Chirifu, Kana Ishiodori, Tadashi Imafuku, Hitoshi Maeda, Yoshihiro Kobashigawa, Hiroshi Morioka, Toru Maruyama

Molecular Pharmaceutics 2024年7月1日
Contribution of the α1-Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α1-Acid Glycoprotein-Knockout Mice.

Yuka Nakamura, Hiroshi Watanabe, Tadashi Imafuku, Issei Fujita, Yuto Ganaha, Toru Takeo, Naomi Nakagata, Hitoshi Maeda, Toru Maruyama

Molecular pharmaceutics 2024年6月11日
Carbon Monoxide Alleviates Post-ischemia–reperfusion Skeletal Muscle Injury and Systemic Inflammation

Kazuaki Taguchi, Shigeru Ogaki, Hitoshi Maeda, Yu Ishima, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama

Biological and Pharmaceutical Bulletin 47(4) 868-871 2024年4月20日
Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment

Isamu Noguchi, Maeda Hitoshi, Kazuki Kobayashi, Taisei Nagasaki, Hiromasa Kato, Hiroki Yanagisawa, Naoki Wada, Gai Kanazawa, Tsubasa Kaji, Hiromi Sakai …

Free Radical Biology and Medicine 2024年4月
Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction.

Kentaro Oniki, Masatsune Ogura, Erika Matsumoto, Hiroshi Watanabe, Tadashi Imafuku, Yuri Seguchi, Yuichiro Arima, Koichiro Fujisue, Kenshi Yamanaga, Eiichiro Yamamoto …

Journal of atherosclerosis and thrombosis 2024年2月20日
Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis

Yuki Minayoshi, Hitoshi Maeda, Keisuke Hamasaki, Taisei Nagasaki, Mei Takano, Ryo Fukuda, Yuki Mizuta, Motohiko Tanaka, Yutaka Sasaki, Masaki Otagiri …

Pharmaceuticals 17(2) 260-260 2024年2月19日
α1酸性糖タンパク質のマクロファージ活性化を介した腫瘍細胞のp53発現制御による腫瘍促進作用(Pro-tumor effect of α1-acid glycoprotein on p53 expression in tumor cells via macrophage activation)

藤原章雄, 田中隆聖, 潘程, 矢野浩夢, 白石大偉輔, 入來豊久, 丸山徹, 菰原義弘

日本病理学会会誌 113(1) 294-294 2024年2月
Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis

Ryota Murata, Hiroshi Watanabe, Ryotaro Iwakiri, Mayuko Chikamatsu, Takao Satoh, Isamu Noguchi, Kengo Yasuda, Ayano Nishinoiri, Takuma Yoshitake, Hiroto Nosaki …

Heliyon 10(3) e25485-e25485 2024年2月
Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxidative Pathways

Ikeda-Imafuku, M., Fukuta, T., Tuan Giam, Chuang, V., Sawa, T., Maruyama, T., Otagiri, M., Ishida, T., Ishima, Y.

Pharmaceuticals 17(1) 2024年1月18日査読有り
Therapeutic Effects of Albumin-Fused BMP7 on 2 Experimental Models of Liver Fibrosis

Mei Takano, Hiroshi Watanabe, Shota Toda, Kento Nishida, Tadashi Imafuku, Yuki Minayoshi, Takehiro Nakano, Hitoshi Maeda, Toru Maruyama

Biological and Pharmaceutical Bulletin 46(10) 1421-1426 2023年10月1日
Carbon Monoxide-Loaded Red Blood Cell Prevents the Onset of Cisplatin-Induced Acute Kidney Injury

Taisei Nagasaki, Hitoshi Maeda, Hiroki Yanagisawa, Kento Nishida, Kazuki Kobayashi, Naoki Wada, Isamu Noguchi, Ryotaro Iwakiri, Kazuaki Taguchi, Hiromi Sakai …

Antioxidants 12(9) 1705-1705 2023年9月1日
Encapsulation of an Antioxidant in Redox-Sensitive Self-Assembled Albumin Nanoparticles for the Treatment of Hepatitis

Kengo Yasuda, Hitoshi Maeda, Ryo Kinoshita, Yuki Minayoshi, Yuki Mizuta, Yuka Nakamura, Shuhei Imoto, Koji Nishi, Keishi Yamasaki, Mina Sakuragi …

ACS Nano 2023年8月14日
ω3系脂肪酸によるAKI to CKD抑制効果と脂肪酸活性代謝物の同定

徳丸碧海, 渡邊博志, 今福匡司, 佐藤崇雄, 稲住知明, 前田仁志, 杉本幸彦, 丸山徹

脂質生化学研究 65 147-148 2023年5月
Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease.

Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, Ryota Murata, Masako Miyahisa, Ayano Nishinoiri, Tadashi Imafuku, Mei Takano, Nanaka Arimura, Kohichi Yamada …

Journal of controlled release : official journal of the Controlled Release Society 355 42-53 2023年3月
Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation

Nanaka Arimura, Hiroshi Watanabe, Hiromasa Kato, Tadashi Imafuku, Takehiro Nakano, Miyu Sueyoshi, Mayuko Chikamatsu, Kai Tokumaru, Taisei Nagasaki, Hitoshi Maeda …

Toxins 15(3) 179-179 2023年2月26日
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease.

Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata …

Nutrients 15(4) 2023年2月4日